RCMNY
Rubric Capital Management (New York)’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108M | Buy |
3,909,806
+526,567
| +16% | +$14.6M | 1.63% | 14 |
|
|
2025
Q1 | $75.1M | Buy |
3,383,239
+764,136
| +29% | +$17M | 1.35% | 22 |
|
|
2024
Q4 | $51.8M | Buy |
2,619,103
+200,000
| +8% | +$3.96M | 0.66% | 29 |
|
|
2024
Q3 | $60.5M | Hold |
2,419,103
| – | – | 0.99% | 26 |
|
|
2024
Q2 | $45.2M | Buy |
2,419,103
+223,094
| +10% | +$4.17M | 1.18% | 35 |
|
|
2024
Q1 | $43.3M | Sell |
2,196,009
-711,492
| -24% | -$14M | 1.28% | 29 |
|
|
2023
Q4 | $51M | Sell |
2,907,501
-169,948
| -6% | -$2.98M | 1.06% | 21 |
|
|
2023
Q3 | $53.5M | Sell |
3,077,449
-300,715
| -9% | -$5.22M | 2.01% | 15 |
|
|
2023
Q2 | $47.6M | Buy |
3,378,164
+602,528
| +22% | +$8.48M | 2.03% | 20 |
|
|
2023
Q1 | $29.9M | Buy |
2,775,636
+1,206,133
| +77% | +$13M | 0.77% | 31 |
|
|
2022
Q4 | $23.5M | Buy |
1,569,503
+123,396
| +9% | +$1.85M | 1.03% | 34 |
|
|
2022
Q3 | $18.6M | Buy |
1,446,107
+922,579
| +176% | +$11.8M | 0.94% | 35 |
|
|
2022
Q2 | $5.07M | Buy |
+523,528
| New | +$5.07M | 0.27% | 60 |
|
|
2021
Q4 | – | Sell |
-153,618
| Closed | -$1.75M | – | 76 |
|
|
2021
Q3 | $1.75M | Buy |
+153,618
| New | +$1.75M | 0.05% | 55 |
|